Tigenix Sa Ord


By |


TiGenix NV is a biopharmaceutical company. It exploits anti-inflammatory properties of stem cells to develop therapies from its proprietary technology platforms for serious medical conditions in the areas of high unmet medical need. The firm's product candidates include Cx601, Cx611, and AlloCSC-01. The firm's products target automimmune, inflammatory and heart diseases. It has Biopharmaceutical operating segment.

Contact Information

Website: www.tigenix.com
Email: investor@tigenix.com
Main Phone: +32 16396060
Address: Romeinse straat 12
Address 2: Box 2, Heverlee, Vlaams-Brabant
City / Town: Leuven
Country: BEL
Postal Code: 3001

Issuer Information

Exchange: GREY
CEO: Eduardo Bravo Fern√°ndez de Araoz
Employees: 89
$ 2.04 $ 0. (0.00%)
Last Price 2.04 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 2.04
Last Trade Volume 0 52 Wk Hi 2.14 52 Wk Low 1.18
Market Cap 628.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 307,973,027.00 EPS (TTM) -0.34 PE Ratio N/A Exchange Greys